CRYOTHERAPEUTICS
CryoTherapeutics is focusing on the development, demonstration of clinical benefit, and early-stage commercialization of a proprietary cryotherapy system for use in the treatment of coronary artery disease that causes heart attacks. The safety and efficacy of cryoenergy in the cardiovascular system has been demonstrated and CryoTherapeutics intends to extend the benefits of cryoenergy to the problem of diseased coronary arteries.
CRYOTHERAPEUTICS
Industry:
Biotechnology Clinical Trials Health Care Medical Therapeutics
Founded:
2009-01-01
Address:
Potsdam, Brandenburg, Germany
Country:
Germany
Website Url:
http://www.cryotherapeutics.com
Total Employee:
1+
Status:
Active
Contact:
49 331 2300920
Total Funding:
18.7 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API WordPress Apache Sitelinks Search Box Euro Microsoft Exchange Online Office 365 Mail
Similar Organizations
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Current Employees Featured
Bertrand Grimmonpre CFO @ CryoTherapeutics
CFO
Maurice Buchbinder CMO @ CryoTherapeutics
CMO
John Yianni CEO @ CryoTherapeutics
CEO
2009-12-01
Founder
Investors List
Creathor Ventures
Creathor Ventures investment in Series B - CryoTherapeutics
Getz Brothers
Getz Brothers investment in Series B - CryoTherapeutics
Peppermint Venture Partners
Peppermint Venture Partners investment in Series B - CryoTherapeutics
Meusinvest (Noshaq)
Meusinvest (Noshaq) investment in Series B - CryoTherapeutics
High-Tech Grunderfonds
High-Tech Grunderfonds investment in Series B - CryoTherapeutics
Creathor Ventures
Creathor Ventures investment in Series B - CryoTherapeutics
Getz Brothers
Getz Brothers investment in Series B - CryoTherapeutics
Peppermint Venture Partners
Peppermint Venture Partners investment in Series B - CryoTherapeutics
KfW
KfW investment in Series B - CryoTherapeutics
NRW.BANK
NRW.BANK investment in Series B - CryoTherapeutics
Official Site Inspections
http://www.cryotherapeutics.com Semrush global rank: 6.69 M Semrush visits lastest month: 874
- Host name: 217-160-0-130.elastic-ssl.ui-r.com
- IP address: 217.160.0.130
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
More informations about "CryoTherapeutics"
CryoTherapeutics - Crunchbase Company Profile
CryoTherapeutics is focusing on the development, demonstration of clinical benefit, and early-stage commercialization of a proprietary cryotherapy system …See details»
About Us - CryoTherapeutics
CryoTherapeutics is developing its CTS system, designed to provide intracoronary cryotherapy treatment for patients with high-risk plaque lesions (also called vulnerable plaque) , who are …See details»
Management Team - CryoTherapeutics
DR. JOHN YIANNI, CEO PhD in Biophysics, Founder, CEO, Board member of several medical device companies (Biocompatibles, Thermocore, Reverse Medical); launched first coated …See details»
CryoTherapeutics - Funding, Financials, Valuation & Investors
CryoTherapeutics is focusing on the development, demonstration of clinical benefit & commercialization of a proprietary cryotherapy system. New. Resources. ... How much funding …See details»
CryoTherapeutics Company Profile - Office Locations ... - Craft
CryoTherapeutics is focusing on the development, demonstration of clinical benefit, and early-stage commercialization of a proprietary cryotherapy system for use in the treatment of …See details»
CryoTherapeutics - Contacts, Employees, Board Members, …
CryoTherapeutics is focusing on the development, demonstration of clinical benefit & commercialization of a proprietary cryotherapy system.See details»
CryoTherapeutics - Products, Competitors, Financials, Employees ...
CryoTherapeutics was founded in 2009. Where is CryoTherapeutics's headquarters? CryoTherapeutics's headquarters is located at Rue Alfred Deponthière 48, Loncin. What is …See details»
CryoTherapeutics - PitchBook
CryoTherapeutics General Information Description. Developer of a cryotherapy system designed to offer treatment for coronary artery diseases. The company's system offers a novel catheter …See details»
CryoTherapeutics - Raised $47.5M Funding from 15 investors
Feb 23, 2025 CryoTherapeutics has raised a total funding of $47.5M over 7 rounds from 15 investors. Investors include KfW, Earlybird and 13 others. Their latest funding round was of …See details»
Our investors - CryoTherapeutics
Our investor base is comprised of private venture capital groups and also public funding bodies located in Belgium and Germany. Peppermint Venture PartnersSee details»
Cryotherapeutics • life science startup - HTGF
CryoTherapeutics GmbH (CryoTherapeutics), the developer of a proprietary cryotherapy system for use in the treatment of coronary artery disease, announced today that it has completed an …See details»
CryoTherapeutics announces €10 Million Series B extension round
Apr 2, 2024 CryoTherapeutics announces €10 Million Series B extension round and promising clinical data for its innovative cryotherapy system to prevent heart attacks. Press release, 02 …See details»
CryoTherapeutics receives additional funding of € 12.3 million and ...
Awans, Belgium, 17 February 2022 - CryoTherapeutics, focusing on the development, demonstration of clinical benefit, and early-stage commercialization of a proprietary …See details»
CryoTherapeutics - Tech Stack, Apps, Patents & Trademarks
CryoTherapeutics uses 12 technology products and services including HTML5, Google Fonts, and jQuery, according to G2 Stack. CryoTherapeutics is actively using 11 technologies for its …See details»
Clinical Accelerator announces collaboration with …
Jan 23, 2023 Clinical Accelerator, a full-service, medical device focused contract research organization, is pleased to announce a new partnership with CryoTherapeutics – an early …See details»
CryoTherapeutics’ Cool Approach to a Hot Problem
May 21, 2024 Now CryoTherapeutics believes it has found a way to treat it. Belgium-based CryoTherapeutics was founded just over a decade ago when the concept of vulnerable plaque …See details»
Cryotherapy - Global Wellness Institute
Whole-body cryotherapy (WBC) is a therapeutic technique where the entire body is exposed to extremely cold air—typically between -110°C to -160°C (-166°F to -256°F)—for a short period, …See details»
Nutcracker Therapeutics CEO Dr. Igor Khandros Retires as
13 hours ago Board of directors member, Cynthia Collins, will serve as executive chair; Dr. Khandros will remain on the board of Nutcracker Therapeutics; EMERYVILLE, Calif.- …See details»
What we do - CryoTherapeutics
CryoTherapeutics is an early-stage European innovator developing a catheter for use by interventional cardiologists to treat atherosclerotic plaque that causes heart attack by …See details»
Next Steps for the Company - CryoTherapeutics
We have recently commenced our first clinical study and are working on refinement of the technology for wide clinical use and commercialisation.See details»